inTEST Corporation
AMEX:INTTSemiconductors
+$0.85 today
- Market cap
- $159.43M
- Beta
- 1.48
- P/E (TTM)
- 386.0
- EPS (TTM)
- $0.05
Volume 0.14M
Average 0.32M
INTT Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
inTEST CorporationAMEX: INTT
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development grows in line with its trailing trend
Q1 FY2026 research & development of $2.59M rose 5.7% year over year, behind the +6.3% change in trailing-twelve-month research & development. Sequentially, it rose 7.3% from the prior quarter. Over 3 fiscal years it compounded at +7.8% a year.
Context
- Research & development amounted to 8.3% of revenue in FY2025, up 1.8 pp from a year earlier.
- Research & development increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +5.7% toward the trailing-twelve-month pace of +6.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 9.44M USD
- Year-over-year change
- +10.4%
- 4-year CAGR
- +14.3%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 9.44M | +10.4% |
| FY2024 | 2024-12-31 | 8.55M | +12.2% |
| FY2023 | 2023-12-31 | 7.62M | +1.2% |
| FY2022 | 2022-12-31 | 7.53M | +36.1% |
| FY2021 | 2021-12-31 | 5.53M | — |
Research & Development vs competitors
How INTT compares with its peers on the latest reported figures
- INTT's LTM Mar 2026 research & development of $9.58M is the 9th highest of the 11 companies compared; the peer median is $77.36M.
- Its year-over-year change of +6.3% is the 9th highest of 11, against a peer median of +10.9%.
- Research & development amounts to 7.9% of revenue for INTT, versus a peer median of 12.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $559.87M | +16.1% | +4.6% | 12.5% | |
| LTM Jul 2026 | $161.53M | +8.0% | +3.0% | 17.0% | |
| LTM Sep 2026 | $128.86M | +7.4% | +4.9% | 17.7% | |
| LTM Sep 2026 | $117.8M | +10.6% | +11.6% | 13.2% | |
| LTM Jun 2026 | $97.2M | +11.1% | -0.1% | 18.6% | |
| LTM Jun 2026 | $57.52M | +37.0% | +18.8% | 11.3% | |
| LTM Sep 2026 | $34.9M | +15.2% | +3.9% | 1.4% | |
| LTM May 2026 | $12.63M | +20.7% | +21.0% | 24.8% | |
| LTM Mar 2026 | $9.58M | +6.3% | +7.8% | 7.9% | |
| LTM Mar 2026 | $2.61M | -23.1% | -25.4% | 3.3% | |
| LTM Mar 2026 | $391K | +3.2% | +0.8% | 0.7% | |
| Peer median (excluding INTT) | $77.36M | +10.9% | +4.3% | 12.9% | |
Competitors are the stored peer set for INTT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 84.88M | 116.83M | 123.3M | 130.69M | 113.83M |
| Cost of Revenue | 43.65M | 63.39M | 66.32M | 75.27M | 64.91M |
| Gross Profit | 41.22M | 53.44M | 56.98M | 55.42M | 48.92M |
| Gross Margin | 48.6% | 45.7% | 46.2% | 42.4% | 43.0% |
| Research & Development | 5.53M | 7.53M | 7.62M | 8.55M | 9.44M |
| Selling, General & Admin | 26.95M | 35.19M | 38.92M | 43.48M | 39.01M |
| Operating Expenses | 32.77M | 42.72M | 46.54M | 52.03M | 52.65M |
| Depreciation & Amortization | 3.15M | 4.73M | 4.68M | 5.44M | 6.8M |
| EBITDA | 11.64M | 15.51M | 16.41M | 9.74M | 4.02M |
| EBITDA Margin | 13.7% | 13.3% | 13.3% | 7.5% | 3.5% |
| Operating Income | 8.46M | 10.72M | 10.44M | 3.39M | (3.73M) |
| Operating Margin | 10.0% | 9.2% | 8.5% | 2.6% | -3.3% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 89K | 635K | 679K | 846K | 450K |
| Other Income / Expenses | (57K) | (576K) | 609K | 60K | 503K |
| Income Before Tax | 8.4M | 10.15M | 11.05M | 3.45M | (3.22M) |
| Pre-Tax Margin | 9.9% | 8.7% | 9.0% | 2.6% | -2.8% |
| Income Tax Expense | 1.12M | 1.68M | 1.71M | 563K | (695K) |
| Net Income | 7.28M | 8.46M | 9.34M | 2.89M | (2.53M) |
| Net Margin | 8.6% | 7.2% | 7.6% | 2.2% | -2.2% |
| EPS (Basic) | 0.70 | 0.79 | 0.82 | 0.24 | (0.21) |
| EPS (Diluted) | 0.68 | 0.78 | 0.79 | 0.24 | (0.21) |
| Weighted Avg Shares | 10.46M | 10.67M | 11.46M | 12.15M | 12.2M |
| Weighted Avg Shares (Diluted) | 10.73M | 10.86M | 11.78M | 12.24M | 12.2M |
inTEST Corporation
AMEX:INTT
Intrinsic Alpha fair value
Locked
Current Price
$12.42
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.